首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >Farnesoid X Receptor Agonist Obeticholic Acid Raises LDL-cholesterol and reduces HDL-cholesterol in the Diet-induced NASH (DIN) Hamster, a Novel Preclinical Model for Evaluating Efficacy and Side effects of Drugs targeting Non-Alcoholic Liver Diseases
【24h】

Farnesoid X Receptor Agonist Obeticholic Acid Raises LDL-cholesterol and reduces HDL-cholesterol in the Diet-induced NASH (DIN) Hamster, a Novel Preclinical Model for Evaluating Efficacy and Side effects of Drugs targeting Non-Alcoholic Liver Diseases

机译:Farnesoid X受体激动剂奥贝胆酸在饮食诱导的NASH(DIN)仓鼠中升高LDL-胆固醇并降低HDL-胆固醇,这是一种新型的临床前模型,可评估针对非酒精性肝病的药物的功效和副作用

获取原文
获取原文并翻译 | 示例
           

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号